VRTX
$499.74-1.77%
as of close, Oct 16, 2026
☾ AH $499.74 -1.77%
Vertex Pharmaceuticals IncorporatedStock · HealthcareNasdaq-100 0.5%Nasdaq Composite 0.2%S&P 500 Equal Weight 0.2%S&P 500 0.2%Russell 1000 0.2%Russell 3000 0.2%US Stock Market 0.2%MSCI World 0.1%MSCI ACWI 0.1%
Vertex Pharmaceuticals Incorporated monthly returns
Vertex Pharmaceuticals Incorporated has averaged 2.05% per month, positive in 54% of months. Month-by-month returns for Vertex Pharmaceuticals Incorporated (VRTX) below, through October 16, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.
Average month
+2.0%
418 months
Best month
+77.1%
Feb 2000
Worst month
-51.1%
Sep 2001
Positive months
54%
of all months
Vertex Pharmaceuticals Incorporated monthly returns#
| Month | Path | Total return |
|---|---|---|
| Oct 2026 | -4.4% | |
| Sep 2026 | -4.0% | |
| Aug 2026 | +14.1% | |
| Jul 2026 | -4.5% | |
| Jun 2026 | +11.6% | |
| May 2026 | +4.7% | |
| Apr 2026 | -4.3% | |
| Mar 2026 | -10.1% | |
| Feb 2026 | +5.7% | |
| Jan 2026 | +3.6% | |
| Dec 2025 | +4.6% | |
| Nov 2025 | +1.9% | |
| Oct 2025 | +8.7% | |
| Sep 2025 | +0.2% | |
| Aug 2025 | -14.4% | |
| Jul 2025 | +2.6% | |
| Jun 2025 | +0.7% | |
| May 2025 | -13.2% | |
| Apr 2025 | +5.1% | |
| Mar 2025 | +1.0% | |
| Feb 2025 | +3.9% | |
| Jan 2025 | +14.6% | |
| Dec 2024 | -14.0% | |
| Nov 2024 | -1.6% | |
| Oct 2024 | +2.3% | |
| Sep 2024 | -6.2% | |
| Aug 2024 | +0.0% | |
| Jul 2024 | +5.8% | |
| Jun 2024 | +2.9% | |
| May 2024 | +15.9% | |
| Apr 2024 | -6.0% | |
| Mar 2024 | -0.6% | |
| Feb 2024 | -2.9% | |
| Jan 2024 | +6.5% | |
| Dec 2023 | +14.7% | |
| Nov 2023 | -2.0% | |
| Oct 2023 | +4.1% | |
| Sep 2023 | -0.2% | |
| Aug 2023 | -1.1% | |
| Jul 2023 | +0.1% | |
| Jun 2023 | +8.8% | |
| May 2023 | -5.0% | |
| Apr 2023 | +8.1% | |
| Mar 2023 | +8.5% | |
| Feb 2023 | -10.2% | |
| Jan 2023 | +11.9% | |
| Dec 2022 | -8.7% | |
| Nov 2022 | +1.4% | |
| Oct 2022 | +7.8% | |
| Sep 2022 | +2.8% | |
| Aug 2022 | +0.5% | |
| Jul 2022 | -0.5% | |
| Jun 2022 | +4.9% | |
| May 2022 | -1.7% | |
| Apr 2022 | +4.7% | |
| Mar 2022 | +13.5% | |
| Feb 2022 | -5.4% | |
| Jan 2022 | +10.7% | |
| Dec 2021 | +17.5% | |
| Nov 2021 | +1.1% | |
| Oct 2021 | +2.0% | |
| Sep 2021 | -9.4% | |
| Aug 2021 | -0.6% | |
| Jul 2021 | -0.0% | |
| Jun 2021 | -3.4% | |
| May 2021 | -4.4% | |
| Apr 2021 | +1.5% | |
| Mar 2021 | +1.1% | |
| Feb 2021 | -7.2% | |
| Jan 2021 | -3.1% | |
| Dec 2020 | +3.8% | |
| Nov 2020 | +9.3% | |
| Oct 2020 | -23.4% | |
| Sep 2020 | -2.5% | |
| Aug 2020 | +2.6% | |
| Jul 2020 | -6.3% | |
| Jun 2020 | +0.8% | |
| May 2020 | +14.6% | |
| Apr 2020 | +5.6% | |
| Mar 2020 | +6.2% | |
| Feb 2020 | -1.3% | |
| Jan 2020 | +3.7% | |
| Dec 2019 | -1.3% | |
| Nov 2019 | +13.4% | |
| Oct 2019 | +15.4% | |
| Sep 2019 | -5.9% | |
| Aug 2019 | +8.0% | |
| Jul 2019 | -9.1% | |
| Jun 2019 | +10.4% | |
| May 2019 | -1.7% | |
| Apr 2019 | -8.1% | |
| Mar 2019 | -2.5% | |
| Feb 2019 | -1.1% | |
| Jan 2019 | +15.2% | |
| Dec 2018 | -8.3% | |
| Nov 2018 | +6.7% | |
| Oct 2018 | -12.1% | |
| Sep 2018 | +4.5% | |
| Aug 2018 | +5.3% | |
| Jul 2018 | +3.0% | |
| Jun 2018 | +10.4% | |
| May 2018 | +0.5% | |
| Apr 2018 | -6.0% | |
| Mar 2018 | -1.8% | |
| Feb 2018 | -0.5% | |
| Jan 2018 | +11.4% | |
| Dec 2017 | +3.9% | |
| Nov 2017 | -1.3% | |
| Oct 2017 | -3.8% | |
| Sep 2017 | -5.3% | |
| Aug 2017 | +5.7% | |
| Jul 2017 | +17.8% | |
| Jun 2017 | +4.3% | |
| May 2017 | +4.5% | |
| Apr 2017 | +8.2% | |
| Mar 2017 | +20.7% | |
| Feb 2017 | +5.5% | |
| Jan 2017 | +16.6% | |
| Dec 2016 | -9.7% | |
| Nov 2016 | +7.6% |
Monthly total return (since Nov 2021)#
-15%-10%-5%0%5%10%15%
Nov 2021+1.1%
Dec 2021+17%
Jan 2022+11%2022
Feb 2022-5.4%
Mar 2022+13%
Apr 2022+4.7%
May 2022-1.7%
Jun 2022+4.9%
Jul 2022-0.49%
Aug 2022+0.48%
Sep 2022+2.8%
Oct 2022+7.8%
Nov 2022+1.4%
Dec 2022-8.7%
Jan 2023+12%2023
Feb 2023-10%
Mar 2023+8.5%
Apr 2023+8.1%
May 2023-5.0%
Jun 2023+8.8%
Jul 2023+0.12%
Aug 2023-1.1%
Sep 2023-0.17%
Oct 2023+4.1%
Nov 2023-2.0%
Dec 2023+15%
Jan 2024+6.5%2024
Feb 2024-2.9%
Mar 2024-0.65%
Apr 2024-6.0%
May 2024+16%
Jun 2024+2.9%
Jul 2024+5.8%
Aug 2024+0.03%
Sep 2024-6.2%
Oct 2024+2.3%
Nov 2024-1.6%
Dec 2024-14%
Jan 2025+15%2025
Feb 2025+3.9%
Mar 2025+1.0%
Apr 2025+5.1%
May 2025-13%
Jun 2025+0.71%
Jul 2025+2.6%
Aug 2025-14%
Sep 2025+0.16%
Oct 2025+8.7%
Nov 2025+1.9%
Dec 2025+4.6%
Jan 2026+3.6%2026
Feb 2026+5.7%
Mar 2026-10%
Apr 2026-4.3%
May 2026+4.7%
Jun 2026+12%
Jul 2026-4.5%
Aug 2026+14%
Sep 2026-4.0%
Oct 2026-4.4%
Vertex Pharmaceuticals Incorporated returns by calendar month#
Every month of every year since 1992, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.
October 2026 so far: -4.41% — 21st of 35 Octobers since 1992 at the last close; the average October returned +0.1%.
| Month | −80%0+80% | Average | Median | Up | Best | Worst |
|---|---|---|---|---|---|---|
| Jan | +3.4% | +3.7% | 66% | +29.1% 2006 | -27.9% 2016 | |
| Feb | +0.2% | -1.1% | 46% | +77.1% 2000 | -26.1% 2001 | |
| Mar | -2.2% | -1.8% | 43% | +36.5% 2008 | -35.5% 2000 | |
| Apr | +1.6% | +3.1% | 60% | +39.7% 2013 | -23.7% 2002 | |
| May | +7.7% | +4.1% | 57% | +56.0% 2012 | -17.0% 1992 | |
| Jun | +3.2% | +0.9% | 57% | +42.6% 2000 | -23.1% 1992 | |
| Jul | -0.7% | -0.3% | 46% | +21.3% 2002 | -19.3% 2001 | |
| Aug | +4.6% | +2.6% | 63% | +73.6% 2000 | -26.9% 1998 | |
| Sep | +1.7% | -0.6% | 46% | +50.8% 1998 | -51.1% 2001 | |
| Oct | +0.1% | +1.9% | 56% | +35.8% 2001 | -23.4% 2020 | |
| Nov | -1.5% | -0.1% | 50% | +25.0% 1992 | -40.0% 2000 | |
| Dec | +6.5% | +5.5% | 65% | +31.8% 1999 | -15.5% 2006 |
Methodology#
Monthly returns are total returns (dividends reinvested), computed from VRTX's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Vertex Pharmaceuticals Incorporated's average monthly return?
- Vertex Pharmaceuticals Incorporated (VRTX) has averaged about 2.05% per month, positive in roughly 54% of months. The best month was Feb 2000 (+77.1%) and the worst was Sep 2001 (-51.1%).
More on Vertex Pharmaceuticals Incorporated
By month for: S&P 500 · S&P 500 Equal Weight · US Stock Market · Nasdaq-100